Daily non-political popular news in brief.

Bitter Pill: Costs surge for new schizophrenia drugs

12-09-2006 · Science News Online

Medications widely prescribed to treat schizophrenia cost hundreds of dollars more each month than does a less popular, older medication that has similar success at alleviating symptoms of the disorder.

Keywords: bitter, pill, costs, surge, schizophrenia, drugs, cost, drug

« Previous | Next »

Similar news on "Bitter Pill: Costs surge for new schizophrenia drugs":

Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
06-11-2007 · EurekAlert!
Slicing certain pills in half could slice a hefty amount off of Americas prescription drug costs. While only some types of pills can be split safely, they include popular cholesterol-lowering drugs. Now, the first prospective randomized controlled trial of pill-splitting gives more evidence of how the practice could be used.
Similar news · Read more »
Medication costs infrequently addressed when newly prescribed, UCLA study finds
11-08-2006 · EurekAlert!
A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.But questions about pricing and prescription drug insurance coverage are critical -- the high costs of drugs, including out-of-pocket payouts such as co-payments, are linked to patient non-adherence in maintaining their dosage schedules
Similar news · Read more »
New study looks at long-term drug costs for treating AIDS in Brazil
11-12-2007 · EurekAlert!
AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.
Similar news · Read more »
Government's reliance on free market economics makes essential drug prices too high for the poor
03-26-2007 · EurekAlert!
Research in Malaysia, published in the latest PLoS Medicine, has established that drugs considered essential for adequate health care are often priced beyond the reach of the poorer members of society. It would cost, for example, three days wages for a low-paid government worker to buy a month’s supply of a commonly prescribed stomach ulcer pill.
Similar news · Read more »
Cost control measures limit patient and physician choice in psychotropic medications
03-01-2007 · EurekAlert!
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
Similar news · Read more »
MIT: 'Micro' livers could aid drug screening
11-18-2007 · EurekAlert!
MIT researchers have devised a novel way to create tiny colonies of living human liver cells that model the full-sized organ. The work could allow better screening of new drugs that are potentially harmful to the liver and reduce the costs associated with their development.
Similar news · Read more »
'Micro' livers could aid drug screening
11-19-2007 · Massachusetts Institute of Technology (MIT)
MIT researchers have devised a novel way to create tiny colonies of living human liver cells that model the full-sized organ. The work could reduce costs and allow better screening of new drugs that are potentially harmful to the liver.
Similar news · Read more »
Antibody reduces incidence of acute rejection in high-risk kidney transplant patients
11-08-2006 · EurekAlert!
Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first direct comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by Washington University School of Medicine in St. Louis shows that one -- anti-thymocyte globulin -- is superior. The results also suggest the drug could potentially save millions of dollars in health care costs.
Similar news · Read more »
Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions
01-21-2008 · EurekAlert!
Changing the way consumers pay for prescription drugs so that the system more closely resembles paying for cell phones or computer software could increase drug use without altering patients' out-of-pocket spending, health plan costs or drug company profits, according to researchers.
Similar news · Read more »
Health providers could save billions without compromising healthcare says drug study
01-17-2007 · EurekAlert!
Switching patients to more cost-effective drugs for cholesterol and blood pressure problems could reduce health budgets by billions without compromising clinical care, according to a study in the January issue of IJCP, the International Journal of Clinical Practice. No adverse events were reported after patients were switched -- the new cholesterol drugs delivered the same results as the previous drug and the new blood pressure drugs delivered improved performance.
Similar news · Read more »